Akhbar fm أخبار آف آم للعالم العربي و الاجنبي Akhbar fm أخبار آف آم للعالم العربي و الاجنبي

كل ما تبحث عنه موجود هنا

Bernie Sanders asks why Catalyst Pharmaceutical is pricing a once-free drug at $375,000

The drug in question is called Firdapse, which was approved by the U.S. Food and Drug Administration in November last year for the treatment of Lambert-Eaton myasthenic syndrome, or LEMS, in adults.
The FDA describes LEMS as "a rare autoimmune disorder that affects the connection between nerves and muscles and causes weakness and other symptoms in affected patients."
Sanders writes that the active ingredient in Firdapse, 3,4-diaminopyridine, has been used to treat LEMS for nearly 30 years and that "the clinical effectiveness had been established over decades in Europe and the United States."
Sanders said the cost of the drug ranges from $1,600 to $6,000 per year. 
"Until now, patients have been able to access an unapproved version of this drug for free through a Food and Drug Administration compassionate use program," Sanders wrote to Catalyst, adding, "Simply put, this is corporate greed.
Sanders is asking Catalyst for information behind the cost and pricing of Firdapse, as well as other questions such as, "How many patients will suffer or die due to Catalyst's decision to set the annual list price of Fridapse at $375,000?"
The high cost of prescription medicine has been blamed as one of the drivers of rising U.S. health care costs. In January, the Trump administration announced a plan to eliminate some rebates paid by drugmakers in government programs such as Medicare to lower the prescription cost


إذا أعجبك محتوى مدونتنا نتمنى البقاء على تواصل دائم ، فقط قم بإدخال بريدك الإلكتروني للإشتراك في بريد المدونة السريع ليصلك جديد المدونة أولاً بأول ، كما يمكنك إرسال رساله بالضغط على الزر المجاور ...

إتصل بنا